115. Hereditary periodic paralysis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 2 / Drugs : 3 - (DrugBank : 3) / Drug target genes : 18 - Drug target pathways : 9
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Acetazolamide
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States
Flecainide + BETA-blocker
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2025 Phase 2 NCT06205550 -
Potassium
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States
Flecainide + BETA-blocker
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2025 Phase 2 NCT06205550 -
Potassium
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States